Zhang, Zhaoyue
Bhatt, Vrushank
Wang, Wenping
Alogaili, Fawzi
Hu, Zhixian
Dobrescu, Ioana
Lee, Joel
Xu, Xincheng
White, Eileen P.
Rabinowitz, Joshua D.
Guo, Jessie Yanxiang https://orcid.org/0000-0001-9212-7954
Article History
Received: 6 May 2026
Accepted: 8 September 2026
First Online: 17 September 2026
Declarations
Ethics approval and consent to participate: Mouse work was approved by the Rutgers Institutional Animal Care and Use Committee (PROTO999900099).
Consent for publication: Not applicable.
Competing interests: J.D.R. is a co-founder, director and stockholder in Raze Therapeutics and Farber Partners; a co-founder and stockholder in Fargo Biotechnologies; and an advisor and stockholder in Empress Therapeutics, Bantam Pharmaceuticals, Faeth Therapeutics, Colorado Research Partners and Rafael Pharmaceuticals. Other authors declare that they have no competing interests.